Arcus Biosciences, Inc. (RCUS)

29.21 -4.51% (-1.38)

Over 1Y: +175.3%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

10 20 30
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 32M Q3 '23 — Operating Cash Flow: -63M Q3 '23 — Free Cash Flow: -73M Q3 '23 — Net Income: -71M Q4 '23 — Revenue: 31M Q4 '23 — Operating Cash Flow: -88M Q4 '23 — Free Cash Flow: -94M Q4 '23 — Net Income: -81M Q1 '24 — Revenue: 145M Q1 '24 — Operating Cash Flow: -2M Q1 '24 — Free Cash Flow: -6M Q1 '24 — Net Income: -4M Q2 '24 — Revenue: 39M Q2 '24 — Operating Cash Flow: -94M Q2 '24 — Free Cash Flow: -94M Q2 '24 — Net Income: -93M Q3 '24 — Revenue: 48M Q3 '24 — Operating Cash Flow: 26M Q3 '24 — Free Cash Flow: 25M Q3 '24 — Net Income: -92M Q4 '24 — Revenue: 26M Q4 '24 — Operating Cash Flow: -100M Q4 '24 — Free Cash Flow: -101M Q4 '24 — Net Income: -94M Q1 '25 — Revenue: 28M Q1 '25 — Operating Cash Flow: -132M Q1 '25 — Free Cash Flow: -133M Q1 '25 — Net Income: -112M Q2 '25 — Revenue: 160M Q2 '25 — Operating Cash Flow: -133M Q2 '25 — Free Cash Flow: -133M Q2 '25 — Net Income: 0 Q3 '25 — Revenue: 26M Q3 '25 — Operating Cash Flow: -97M Q3 '25 — Free Cash Flow: -97M Q3 '25 — Net Income: -135M Q4 '25 — Revenue: 33M Q4 '25 — Operating Cash Flow: -120M Q4 '25 — Free Cash Flow: -121M Q4 '25 — Net Income: -106M Q1 '26 — Revenue: 17M Q1 '26 — Operating Cash Flow: -138M Q1 '26 — Free Cash Flow: -138M Q1 '26 — Net Income: -128M Q2 '26 — Revenue: 41M Q2 '26 — Operating Cash Flow: -119M Q2 '26 — Free Cash Flow: -119M Q2 '26 — Net Income: -91M -120M -60M 0 60M 120M 180M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 53.8%
OE margin -459.8%
Oper. margin -415.4%
Accruals 1.5%
EBITDA margin -406.8%
FCF margin -406.0%
OCF margin -405.1%
Profit margin -393.2%
ROA -49.8%
ROCE -66.9%
ROE -99.1%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 2.2×
RPO growth -51.0%
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -40.5×
Cash / Debt 7.0×
Debt payback 0.0 yr
Quick ratio 3.8×
Debt / Eq 0.22×
Cash runway 1.3 yr
F-score 0.0 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales CAGR 4Y -10.4%
Sales/sh Y/Y -62.5%
Sales Q/Q -74.4%
Shares change +19.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.